A specific tsRNA in serum from patients with nasopharyngeal carcinoma: 5′tiRNA-32-ValAAC-2 mediates malignance of nasopharyngeal carcinoma cells

Front. Med. ››

PDF (4983KB)
Front. Med. ›› DOI: 10.1007/s11684-025-1175-x

A specific tsRNA in serum from patients with nasopharyngeal carcinoma: 5′tiRNA-32-ValAAC-2 mediates malignance of nasopharyngeal carcinoma cells

Author information +
History +
PDF (4983KB)

Cite this article

Download citation ▾
. A specific tsRNA in serum from patients with nasopharyngeal carcinoma: 5′tiRNA-32-ValAAC-2 mediates malignance of nasopharyngeal carcinoma cells. Front. Med. DOI:10.1007/s11684-025-1175-x

登录浏览全文

4963

注册一个新账户 忘记密码

References

AI Summary AI Mindmap
PDF (4983KB)

68

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/